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Abstract
Bisphenol A (BPA) exposure results in numerous developmental and functional abnormalities in reproductive organs in
rodent models, but limited data are available regarding BPA effects in the primate uterus. To determine if maternal oral BPA
exposure affects fetal uterine development in a non-human primate model, pregnant rhesus macaques carrying female
fetuses were exposed orally to 400 mg/kg BPA or vehicle control daily from gestation day (GD) 50–100 or GD100–165. Fetal
uteri were collected at the completion of treatment (GD100 or GD165); tissue histology, cell proliferation, and expression of
estrogen receptor alpha (ERa) and progesterone receptor (PR) were compared to that of controls. Gene expression analysis
was conducted using rhesus macaque microarrays. There were no significant differences in histology or in the percentage of
cells expressing the proliferation marker Ki-67, ERa, or PR in BPA-exposed uteri compared to controls at GD100 or GD165.
Minimal differences in gene expression were observed between BPA-exposed and control GD100 uteri. However, at GD165,
BPA-exposed uteri had significant differences in gene expression compared to controls. Several of the altered genes,
including HOXA13, WNT4, and WNT5A, are critical for reproductive organ development and/or adult function. We conclude
that second or third trimester BPA exposure does not significantly affect fetal uterus development based on morphological,
proliferation, and steroid hormone receptor assessments. However, differences in expression of key developmental genes
after third trimester exposure suggest that BPA could alter transcriptional signals influencing uterine function later in life.
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Introduction
The disruptive effects of inappropriate estrogenic chemical
exposure on human female reproductive tract development are
well established. A dramatic example is provided by the potent
synthetic estrogen diethylstilbestrol, which leads to numerous
structural and functional reproductive tract abnormalities as a
consequence of prenatal exposure [1]. Although diethylstilbestrol
is no longer used in pregnant women, there are concerns that
environmental exposures to other estrogenic endocrine disrupting
compounds could affect fetal reproductive tract development.
Bisphenol A (BPA) is a widely used industrial chemical with
estrogenic activity. As a component of polycarbonate plastics and
epoxy resins, BPA is incorporated into food containers, cans,
dental sealants, and thermal receipts. It leaches out of these parent
compounds with heating and degradation and exposure is nearly
ubiquitous in industrialized countries [2,3,4].
BPA binds nuclear estrogen receptors a (ERa) and b to
modulate transcriptional activity, influences non-genomic estro-
gen-mediated signaling, and may affect both thyroid hormone and
glucocorticoid signaling (reviewed in [3]). In animal models, BPA
is an endocrine disrupting compound with regard to development
and function of numerous tissues including the brain, mammary
gland, ovary, and reproductive tract [3,5]. Developmental
exposure of rodents to BPA has lifelong consequences for
reproductive function, including alterations in timing of puberty,
altered estrous cyclicity, and increases in the expression of ERa
and progesterone receptor (PR) in the uterus [3,5]. Effects of BPA
vary by stage of life at time of exposure, and differences in
metabolism and tissue sensitivity may make the fetus more
vulnerable to lower levels of BPA exposure [6]. In women, BPA
levels in amniotic fluid are markedly higher than in maternal
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plasma, suggesting that the human fetus may have significant
exposures during development [7].
There is little definitive information about the human health
effects of BPA. Some epidemiologic studies suggest that BPA
exposure may be associated with adverse health effects, including
developmental outcomes; however, most of these studies have
been case-control, cross-sectional, retrospective, and/or limited in
size (reviewed in [4]). To help address concerns over human BPA
exposure early in life, in this study a rhesus macaque animal model
was used to examine the effects of prenatal exposure to BPA on the
development of several tissues shown previously in rodent models
to be affected by BPA. This model was used because rhesus
macaques (Macaca mulatta) are similar to humans with regard to
BPA metabolism, physiology and pharmacology [8] and share
many features of reproductive organ physiology and development
[9,10]. Results for three of the tissues from this study, ovary,
mammary gland, and brain, have been published [11,12,13]. The
current report describes changes in fetal uterine histology and gene
expression from mid to late gestation and the associated effects of
oral maternal BPA exposure.
Materials and Methods
Ethics Statement
All animal protocols were approved prior to implementation by
the Institutional Animal Care and Use Committee (IACUC) at the
University of California, Davis, and all procedures conformed to
the requirements of the Animal Welfare Act. Activities related to
animal care including housing, feeding, and environmental
enrichment were performed in accordance with IACUC-approved
standard operating procedures (SOPs) at the California National
Primate Research Center (http://www.cnprc.ucdavis.edu).
Briefly, animals were individually housed in stainless steel cages
under a 12:12 hr light-dark cycle at 25–27uC. They were fed
Purina Monkey Chow and water ad lib; environmental enrich-
ments included cereal, seeds, and seasonal produce. Fetuses were
euthanized immediately after delivery and newborns within
24 hours of delivery in a manner consistent with the recommen-
dations of the American Veterinary Medical Association (AVMA)
Guidelines on Euthanasia and Primate Center SOPs (IV
administration of pentobarbital overdose).
Animals and treatments
The rhesus macaques used in these studies were the same cohort
of macaques that received oral treatments described previously
[11,12,13]. Briefly, healthy pregnant females carrying female
fetuses were randomly allocated to one of two treatment groups
that received a daily fruit treat containing either 400 mg/kg
deuterated BPA (CDN Isotopes, Quebec, Canada) or vehicle
(100 ml ethanol). The macaques were subdivided into two groups
based on gestational timing. The ‘‘GD100’’ group (N = 5 BPA-
treated, N = 5 control) was treated from gestational day (GD) 50–
100; delivery was on GD100 by caesarian section. The ‘‘GD165’’
group (N = 6 BPA-treated, N = 6 control) was treated from GD100
until vaginal delivery at approximately GD165. After delivery, the
fetal uterus was removed and cut sagitally from fundus to cervix;
one side was fixed for histological evaluation, and the other half
was frozen for analysis of gene expression. There were five
idiopathic stillbirths (N = 2 control, N = 3 BPA-exposed) in the
GD165 treatment group. Uteri from stillborn fetuses were not
included in the microarray analyses.
Total RNA isolation, microarray analysis, and real-time RT-
PCR
Total RNA was isolated using the RNeasy Mini kit (Qiagen,
Valencia, CA). Gene expression analysis was conducted on RNA
from individual uterus samples using rhesus macaque gene
expression microarrays (V1:015421; Agilent Technologies, Santa
Clara, CA) following the Agilent 1-color analysis protocol. Data
were obtained using Agilent Feature Extraction software (v9.5; 1-
color defaults), which performed error modeling, adjusting for
additive and multiplicative noise. An error-weighted ANOVA and
Benjamini-Hochberg multiple test correction with p-value,0.01
was performed using Rosetta ResolverH (Rosetta Biosoftware,
Kirkland, WA) to identify differentially expressed probes. Addi-
tional analyses were performed using Partek Genomics Suite
(Partek Inc., St. Louis, MO) to create principal component
analyses and hierarchical clustering plots. Pathway and network-
based analyses were performed on differentially expressed probes
using IPA 9.0 (Ingenuity Systems, Redwood City, CA). Analyses
were performed for each comparison on a dataset restricted to
differentially expressed probes having a 2.0-fold (controls, GD100
vs. GD165) or a 1.3-fold (GD165; BPA vs. control) change cutoff
to achieve suitable numbers of probes for the analyses. The
microarray data were deposited in the National Center for
Biotechnology Information Gene Expression Omnibus, accession
no. GSE38421.
For real time RT-PCR, first strand cDNA was generated from
1 mg total RNA. Primers were designed across exon junctions
using Primer3Web 0.4.0 [14] based on rhesus macaque sequences
Figure 1. Histology and ERa, PR, and Ki-67 immunolabeling of
uteri from control and BPA-treated macaques at GD100 and
GD165. Treatment group and staining method or antibody are
indicated. In panels A and B, ‘‘F’’ indicates uterine fundus and ‘‘C’’
indicates uterine cervix. Scale bars = 100 mm.
doi:10.1371/journal.pone.0085894.g001
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(Table S1). Real time RT-PCR was performed on 20 ng cDNA
using SYBRH Green–based detection on an ABI 7200 HT
detector (Applied Biosystems, Foster City, CA) as described
previously [15]. Relative gene expression was calculated using
the DDCt method with cyclophilin A (Ppia) expression for
normalization [16].
Histology and immunohistochemistry
Fixed uterine tissues were paraffin embedded, sectioned at
6 mm, stained with hematoxylin and eosin and examined by a
board-certified pathologist for histologic changes. For immuno-
histochemistry, epitope retrieval was performed using 10 mM
citrate buffer, pH 6.0 in a pressure cooker. Endogenous peroxi-
dase was quenched with 3% hydrogen peroxide and sections were
blocked using 10% horse serum followed by avidin/biotin
blocking reagent (Vector Laboratories, Burlingame, CA). The
following primary monoclonal antibodies and dilutions were used:
anti-ER (1:100; clone ER1D5; Beckman Coulter, Brea, CA); anti-
Ki-67 (1:100; clone MIB-1; DakoCytomation, Carpenteria, CA);
anti-PR (1:50; GeneTex, Irvine, CA), and anti-beta-catenin
(1:100; BD Transduction Laboratories, San Jose, CA). For all
antibodies, the same dilution of mouse IgG1 (BD Pharmingen, San
Diego, CA) was used as an isotype control. Secondary antibody
was from the Vectastain Elite kit (Vector Laboratories) and
diaminobenzamine was used as the chromogen. Sections were
counterstained with hematoxylin.
Quantitation of immunostaining
Slides were scanned and viewed using the AperioH Scanscope
XT Digital Slide Scanner and ImageScope software (Aperio
Technologies, Vista, CA). Five regions per slide of luminal
epithelium 100 microns in length were selected near the uterine
fundus for epithelial cell counts. Five regions per slide of 100
square mm were selected for stromal cell counts. Image analysis
was performed by an observer blinded to treatment status using
AperioH IHC Nuclear Algorithm v. 8.001, which measures the
area, number of positive-stained nuclei, number of counter-stained
nuclei, and the total number of nuclei. For each animal, the
percentage of positive nuclei was calculated as the average of the
five field measurements in the epithelial or stromal regions. The
data were analyzed with Prism 6.0 software (GraphPad, La Jolla,
CA) using the Kruskal-Wallis test and Dunn’s multiple comparison
test with a significance level set at p,0.05. Because there was no
difference in the percentage of positive nuclei in the epithelial and
stromal compartments for any of the antibodies, the data were
combined for presentation.
Results
The dams included in this study were given an oral dose of BPA
that resulted in average serum concentrations of unconjugated
biologically active BPA of ,0.3–0.5 ng/ml [12], which is similar
to levels found in human adults and fetuses [2,3]. Control
Table 1. Summary of histological findings in the uterus.
Microscopic Findings GD100 control GD100 BPA GD165 control GD165 BPA
Number of animals examined 5 5 6 6
No tubulogenesis observed (# animals) 2 0 0 0
Bud formation (# animals) 3 5 6 6
Rudimentary tubulogenesis (# animals) 2 2 6 6
Branching (# animals) 0 0 6 6
Extent of tubulogenesis gradea (range) 0–2 1–2 4–5 4–5
Extent of tubulogenesis gradea (average 6 SE) 1.060.4 1.460.2 4.260.2 4.760.2
Luminal epithelial cell height (mm; range) 24.5–38.7 20.4–40.4 23.6–32.1 27.2–31.8
Luminal epithelial cell height (mm; average 6 SE) 30.562.9 30.463.5 28.761.3 29.460.8
Subnuclear vacuolization gradeb (range) 1–4 1–3 1–5 1–4
Subnuclear vacuolization gradeb (average 6 SE) 2.660.5 2.460.4 2.360.6 2.560.7
aGrades for extent of tubulogenesis: 0 = none present; 1 = bud formation only; 2 = buds and initial tubules, no branching; 3 = tubules predominant, no branching;
4 = tubules predominant, a few branches present; 5 = branching prominent.
bGrades for extent of epithelial subnuclear vacuolization: 0 = No vacuolization present; 1 = Minimal vacuolization (#10% of cells); 2 = Mild vacuolization (11–25% of cells);
3 = Moderate vacuolization (26–50% of cells); 4 = Marked vacuolization (51–75% of cells); 5 = Severe vacuolization (.75% of cells).
doi:10.1371/journal.pone.0085894.t001
Figure 2. Comparison of ERa, PR, and Ki-67 labeling indices at
GD100 and GD165. Graph indicates mean 6 SEM of combined
epithelial and stromal staining for each antibody. Single asterisk,
p,0.05.
doi:10.1371/journal.pone.0085894.g002
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macaques had negligible serum BPA concentrations. There were
no significant differences between treatment groups in the body
weights of the mothers or fetuses at the time of delivery [12].
Histological analysis
Uteri from GD100 fetuses had well-developed myometrium,
endometrial stroma and luminal columnar epithelium (Fig. 1A–D).
Bud formation and rudimentary tubules were evident within the
superficial endometrial epithelium, but no tubular branching or
mature endometrial glands were observed (Table 1). No gross or
histologic uterine lesions were identified. Minimal to marked
cytoplasmic vacuolization, predominantly subnuclear in location,
was present in uterine epithelial cells in all animals, similar to that
reported previously in cynomolgus macaques (Macaca fascicularis)
[9]. There were no differences in the gross or microscopic
appearance of the uteri between control and BPA-exposed
animals, including blinded qualitative assessments of epithelial
cell height and extent of subnuclear vacuolization. There were also
no significant differences in the cellular distribution or nuclear
staining patterns for ERa, PR, or the proliferation marker Ki-67
between GD100 control and BPA-exposure groups (Fig. 1E–J).
Uteri from GD165 fetuses also showed well-developed myome-
trial and endometrial stromal and columnar epithelial layers
(Fig. 1K–N). The major difference at this gestational age was more
advanced glandular morphogenesis indicated by the presence of
increased luminal epithelial invaginations and tubular epithelial
structures within the endometrial stroma; tubular branching was
observed in all GD165 uteri. Tubular development, epithelial cell
height, and subnuclear vacuolization scores did not differ between
treatment groups. Nuclear ERa, PR, and Ki-67 staining was
present in both epithelial and stromal compartments (Fig. 1O–T).
Quantitative analysis demonstrated no significant differences in
the percentage of cells with positive staining for ERa, PR, or Ki-67
when comparing BPA-exposed to control uteri at either develop-
mental time point (Fig. 2). Staining for ERa was present in ,50%
of nuclei in both epithelial and stromal compartments at both time
points. Less than 5% of nuclei in either compartment stained for
PR at GD100. In controls animals, PR staining increased to
,15% at GD165; the increase in PR staining in BPA-exposed
animals did not reach statistical significance. About 20% of the
cells in all groups showed evidence of proliferative activity based
on positive Ki-67 staining. At both GD100 and GD165,
significantly fewer cells were positive for PR compared to ERa
across both treatment groups (Fig. 2).
Microarray analysis: Comparison of GD100 to GD165
control animals
Uterine gene expression profiles showed marked differences in
control animals based on developmental stage. Principal compo-
nent analysis demonstrated clear separation between GD100 and
GD165 animals (Fig. 3A). Of the 20,217 probes on the array, 3645
probes were significantly different after correction for multiple
testing; of these, 406 were altered at least 2-fold. Hierarchical
clustering was performed after filtering the data for significantly
different probes; this analysis indicated clear differences in gene
expression between uteri of macaques at different gestational ages
and low inter-individual variability within each control group
(Fig. 3B). A list of the most highly up- and down-regulated genes
was generated (Table 2). Both up- and down-regulated probes
Figure 3. Microarray analysis of uteri from control macaques at
GD100 and GD165. A. Principal component analysis. B. Hierarchical
analysis. GD100 marked in cyan, GD165 marked in yellow. BPA
treatment group marked in cyan; control group marked in yellow.
Scale bars represent standardized signal intensity.
doi:10.1371/journal.pone.0085894.g003
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from the microarray expression data were validated by real time
RT-PCR (Table S1).
Ingenuity Core analysis identified several gene networks with
significant alterations. The biological functions in the highest
scoring network related to the cell cycle and cell division, including
aurora kinase B, several centromere proteins, and alpha tubulin
isoforms; most of the genes in this network were downregulated
(Fig. 4A). The second network included a hub with several very
highly upregulated myosin genes (Fig. 4B). A third network of note
centered almost completely on tumor necrosis factor (TNF) as a
hub (Fig. 4C). TNF itself was upregulated almost 3-fold, and the
majority of the remaining genes, including many major histocom-
patibility complex (MHC) genes, were upregulated at least that
much.
The biological functions for which the predicted activation state
was significantly increased or decreased in the Ingenuity analysis
are shown in Table S2. Based on the corresponding annotations in
this table, the vast majority of the increased activation state
functions can be explained by increases in hematopoietic cells in
the uterus late in gestation. This finding is consistent with
hemoglobin B being by far the most highly upregulated gene in
the GD165 group (Table 2) and also with the upregulation of a
large number of MHC genes in the TNF-centered network
(Fig. 4C). The decreased activation state functions mainly related
to the cell cycle, and are reflected in the downregulation of cell
cycle genes shown in the top-scoring network (Fig. 4A). The
upstream regulators identified by the Ingenuity analysis included
cell cycle-related genes that were mainly downregulated if they
generally function to promote cell division, e.g., CCND1 and the
E2F genes, and upregulated if they inhibit cell cycle progression,
e.g., RB1, CEBPA, and TP53 (Table S3). Indeed, one of the most
highly upregulated genes, Kruppel-like factor 9 (KLF9) (Table 2),
encodes a PR-interacting protein that modulates expression of
genes important in cell cycle control [17].
Microarray analysis: Comparison of BPA-exposed to
control animals
Gene expression differences between uteri of the GD100 BPA-
exposed and control fetuses were minimal. Principal component
analysis of these two groups demonstrated very little segregation by
treatment; this finding was confirmed by hierarchical cluster
analysis (data not shown). There were only 84 differentially
expressed genes identified; of these, only 5 were altered more than
2-fold. Based on these observations, further comparison of the
microarray data between these groups was not carried out.
In contrast to the findings at GD100, there were significant
differences in gene expression when comparing the GD165 control
and BPA-exposure groups. Principal component analysis demon-
strated segregation by treatment group (Fig. 5A). There were 883
significantly different probes and, of these, 179 were altered at
least 1.5-fold. Hierarchical clustering was performed after filtering
the data for significantly different probes; this analysis indicated
clear differences in gene expression and good consistency within
the treatment groups (Fig. 5B). Both up- and down-regulated
probes from the microarray expression data were validated by real
time RT-PCR (Table S1). A list of the most highly up- and down-
regulated genes was generated (Table 3).
Based on work in mice and women, homeobox transcription
factors encoded by Hox genes and secreted signaling proteins
encoded by Wnt family genes have important roles in female
reproductive tract development [18]. Several HOX and WNT
genes and FZD2, which encodes a WNT receptor, were among
Table 2. Most highly up- and down-regulated genes in uteri from GD165 compared to GD100a.
Gene Gene description Microarray Fold Change (GD165/GD100) p-value
HBB hemoglobin, beta 61.74 9.28E-08
CKM creatine kinase M-type (Creatine kinase, M chain) (M-CK) 33.71 6.74E-03
CLDN10 claudin 10 21.96 3.27E-06
FAM180A family with sequence similarity 180, member A 19.77 1.00E-05
MYH8 myosin, heavy chain 8, skeletal muscle, perinatal 19.27 4.64E-08
SLN sarcolipin 18.39 1.90E-04
KLF9 Kruppel-like factor 9 17.27 9.30E-15
MYL1 myosin, light chain 1, alkali; skeletal, fast 16.74 1.09E-03
CAPN13 calpain 13 16.20 1.18E-03
MYH2 myosin, heavy chain 2, skeletal muscle, adult 14.25 1.57E-09
FDCSP follicular dendritic cell secreted protein 25.67 9.30E-15
OIT3 oncoprotein induced transcript 3 25.82 2.70E-13
CSMD3 CUB and Sushi multiple domains 3 25.87 2.80E-08
TEX15 testis expressed 15 26.38 7.82E-09
GABRA1 gamma-aminobutyric acid (GABA) A receptor, alpha 1 27.78 4.05E-03
LRRTM3 leucine rich repeat transmembrane neuronal 3 27.94 2.60E-04
CRYGC crystallin, gamma C 27.94 1.83E-12
CABS1 calcium-binding protein, spermatid-specific 1 28.14 7.27E-10
PCDH8 protocadherin 8 29.86 1.30E-04
AMBN ameloblastin (enamel matrix protein) 254.78 1.05E-13
aList filtered to keep only the genes with an average microarray intensity value $50 in either group.
doi:10.1371/journal.pone.0085894.t002
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those identified by microarray analysis to be differentially
regulated in response to BPA exposure in the GD165 gestation
group, although the fold changes observed were not high (Table 4).
In addition, expression levels were well above background for
HOXB3, several HOXC and HOXD genes, and WNT2, suggesting
that there may be as yet undefined roles for HOX and WNT
paralogs in primate reproductive tract development.
Two non-overlapping networks generated by the Ingenuity
Core analysis stood out as highly significant. The top functions for
the first of these networks included Post-Translational Modifica-
tion, Protein Degradation, and Protein Synthesis; this network
included several HOX and WNT genes (Fig. 6A). Top functions for
the second network included Cellular and Embryonic Develop-
ment; this network utilized the estrogen receptor as a hub (Fig. 6B).
Differentially expressed molecules were linked by the Ingenuity
analysis into mechanistic networks determined by upstream
regulators. Potential upstream regulators included steroid hor-
mones or regulators of steroid hormone signaling, including
mifepristone, progesterone, androgen receptor, and dihydrotes-
tosterone (Table S4). The molecules comprising the mechanistic
Figure 4. Top Ingenuity networks identified in Control GD100 vs. GD165 comparison. A. Cell Cycle, Cellular Assembly and Organization,
DNA Replication, Recombination, and Repair (score = 40, 29 focus molecules, p value of top functions = 2.78E-08). B. Developmental Disorder,
Neurological Disease, Organismal Injury and Abnormalities (score = 38, 28 focus molecules, p value of top functions = 2.09E-04). C. Inflammatory,
Neurological, and Immunological Diseases (score = 32, 25 focus molecules, p value of top functions = 1.71E-05).
doi:10.1371/journal.pone.0085894.g004
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network regulated by progesterone included the prolactin receptor
and progesterone receptor membrane component 1, which are
positively regulated by progesterone and were expressed more
highly in BPA-exposed animals than controls (Fig. 7).
The overall increases in expression of Wnt signaling-related
mRNAs in BPA-treated macaques at GD165 suggested that
canonical Wnt signaling via beta-catenin might be induced to a
greater extent than in controls. Immunohistochemical staining of
GD165 control uteri revealed localized beta-catenin staining at the
tip of the developing gland structures (Fig. 8A, B). Uteri from BPA-
treated macaques at GD165 appeared to have more intense beta-
catenin staining at this location but also exhibited nuclear beta-
catenin staining in cells not within glandular structures. However,
because of the uneven staining distribution and the different
numbers of gland structures across different sections, we were
unable to effectively quantify the differences in beta-catenin
staining using computer morphometry.
Discussion
Here we utilized a rhesus macaque model to characterize
histology and gene expression in fetal uteri at mid and late
gestation and examined the effects of daily in utero exposure to BPA
on uterine development. In control animals at GD165 there was
increased evidence of uterine glandulogenesis on histology and
extensive changes in the gene expression profiles compared to
GD100. BPA exposure did not result in any significant changes in
fetal uterine histology at either GD100 or GD165; however, there
were significant differences in gene expression in response to BPA
in the GD165 group, particularly in HOX and WNT family genes.
As in humans, major organogenesis occurs in macaques during
the first trimester of pregnancy, and is complete by about GD46
[19]. The BPA exposures in this study were not during the first
trimester and thus were not timed to determine effects on major
organogenesis. Instead, BPA was given during the more subtle
tissue differentiation events of female meiosis and ovarian follicle
formation, which occur during the second and third trimesters,
respectively [12]. As a result, the BPA was given during gestational
periods when little overt morphologic differentiation was occurring
in the uterus except for initial glandular morphogenesis in the
GD165 group. Exposure to BPA in our study did not significantly
alter the appearance of the uterine glands at GD165, suggesting
that BPA did not interfere with the epithelial-stromal signaling
required to initiate this process.
Evaluation of endometrial cell labeling for ERa and PR, which
is induced by ERa activity, revealed that ERa was more highly
expressed than PR at both GD100 and GD165. Expression of PR
was somewhat higher at GD165 than at GD100, coinciding with a
significant increase in expression of KLF9, which encodes a
modulator of PR function. These findings suggest that there is
increased uterine ERa activity and/or PR responsiveness with
fetal age. However, no clear differences in ERa or PR-responsive
genes were noted between GD100 and GD165 control uteri. The
nuclear receptor expression patterns may reflect effects of the
relatively high circulating maternal estrogen and progesterone
levels during pregnancy, which likely contributed to the presence
of subnuclear vacuolization in epithelial cells at both time points
(resembling human early luteal phase endometrium). Quantitative
analysis of ERa, PR, and Ki-67 staining did not reveal any effects
of BPA exposure at GD100 or GD165, indicating that BPA at the
Figure 5. Microarray analysis of uteri from control and BPA-
treated macaques at GD165. A. Principal component analysis. B.
Hierarchical analysis. BPA treatment group marked in cyan; control
group marked in yellow. Scale bars represent standardized signal
intensity.
doi:10.1371/journal.pone.0085894.g005
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dose used did not interfere with expression of these proteins or
alter proliferation. Our study design precluded any examination of
long-term carryover effects of BPA exposure on these endpoints.
Gene expression analysis of uteri from GD165 showed extensive
differences compared to GD100, with major contributions by
hematopoietic genes and cell cycle regulators. Although the cell
origin of the altered hematopoietic gene expression is unclear,
previous studies of Macaca fascicularis have reported an increase in
the vascular supply to the endometrial stroma between GD100
and GD150 [9]. The pattern of expression of cell cycle regulators
was consistent with a decreased uterine growth rate at GD165 as
compared to GD100. This finding suggests that although major
organogenesis is complete by around GD50, the uterus continues
to have actively proliferating cells through GD100 and that this
Table 3. Most highly up- and down-regulated genes in response to late gestation BPA treatment (GD165)a.
Gene Gene description Microarray Fold Change (BPA/Control) p-valueb
PDE11A phosphodiesterase 11A 2.79 6.99E-09
HOXC9 homeobox C9 2.51 1.30E-11
IGHMBP2 immunoglobulin mu binding protein 2 2.50 2.17E-10
CSTL1 cystatin-like 1 precursor 2.50 2.10E-04
HOXC10 homeobox C10 2.46 6.95E-03
IL26 interleukin 26 2.37 1.54E-13
KLK3 kallikrein-related peptidase 3 2.31 1.54E-13
ALX3 ALX homeobox 3 2.25 1.00E-05
DOK6 docking protein 6 2.22 5.00E-05
ABHD1 abhydrolase domain containing 1 2.17 2.20E-04
CDH4 cadherin 4, type 1, R-cadherin (retinal) 22.79 4.31E-03
GDE1 glycerophosphodiester phosphodiesterase 1 22.85 5.84E-09
GJB3 gap junction protein, beta 3, 31kDa 22.86 6.53E-06
TFAP2C transcription factor AP-2 gamma (activating enhancer
binding protein 2 gamma)
23.06 3.80E-04
RNF186 ring finger protein 186 23.12 8.40E-04
HOXA13 homeobox A13 23.13 1.80E-04
FGF10 fibroblast growth factor 10 23.40 1.51E-11
CLIC6 chloride intracellular channel 6 24.89 2.46E-08
CXCL14 chemokine (C-X-C motif) ligand 14 25.32 1.30E-04
SST somatostatin 29.05 8.33E-03
aList filtered to keep only the genes with an average microarray intensity value $50 in either group.
doi:10.1371/journal.pone.0085894.t003








HOXA13 homeobox A13 23.13 1.80E-04 1865.09 536.40
HOXC6 homeobox C6 1.74 3.00E-04 1476.25 3040.11
HOXC8 homeobox C8 1.73 7.90E-04 186.02 350.29
HOXC9 homeobox C9 2.51 1.30E-11 268.87 758.71
HOXC10 homeobox C10 2.46 6.95E-03 29.32 75.50
HOXD1 homeobox D1 1.48 3.85E-03 321.27 500.31
HOXD3 homeobox D3 1.83 3.50E-04 657.45 1349.09
HOXD9 homeobox D9 1.30 9.84E-03 6344.27 9241.96
WNT2 Wingless-type MMTV integration site family member 2 1.99 4.88E-03 426.42 1077.09
WNT4 Wingless-type MMTV integration site family member 4 1.56 6.00E-05 2650.91 4661.60
WNT5A Wingless-type MMTV integration site family member 5a 1.28 1.00E-05 12231.18 17578.10
FZD2 frizzled homolog 2 (Drosophila) 1.14 2.40E-04 6136.87 7883.45
aList filtered to keep only the genes with an average microarray intensity value $50 in either group.
doi:10.1371/journal.pone.0085894.t004
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process may slow somewhat in the final trimester. This observation
is generally consistent with the pattern of circulating maternal
estradiol, which rises rapidly from GD50 to GD80 but then
remains at a plateau until the final week before delivery when it
rises sharply again [20]. However, because a significant decrease
in cell proliferation as indicated by Ki-67 staining was not
observed by immunohistochemistry at GD165 (Fig. 2), the impact
of these cell cycle-related gene expression changes is uncertain.
Three of the differentially regulated genes associated with BPA
exposure in late gestation, HOXA13, WNT4, and WNT5A, are
important for urogenital tract development and function in
humans [21,22,23]. HOX genes encode transcription factors that
establish the body plan and regulate development during
embryogenesis, whereas WNT genes encode secreted signaling
factors that also regulate development, sometimes in cooperation
with HOX genes [24,25,26]. Female reproductive tract anterior-
to-posterior differentiation is driven by differential expression of
the posterior HOXA genes, including HOXA9, HOXA10/A11, and
HOXA13, which are most highly expressed in the oviduct, the
uterus, and the cervix/upper vagina, respectively [27]. The 3-fold
decreased expression of HOXA13 observed here in BPA-exposed
animals is of particular note because function-disrupting mutations
in this gene cause Hand-Foot-Uterus syndrome, which is
characterized by dysplasia of hands and feet along with
genitourinary abnormalities in both females and males [23,28].
HOXA13 repression, if it occurred during uterine organogenesis,
would logically promote similar abnormalities.
Function-disrupting mutations of WNT4, a gene critical for
female sex determination and organogenesis, are associated with
Müllerian aplasia, ovarian follicle depletion, and hyperandrogen-
ism in women [21]. Disruption of both WNT4 alleles results in
numerous developmental defects, including kidney and lung
dysgenesis and female to male sex reversal [29]. Localization of
beta-catenin to the tips of the developing endometrial glands
suggests an important role for canonical WNT signaling in
endometrial tubulogenesis, similar to its documented role in
tubulogenesis during kidney and lung development [30]. WNT4
protein is detected in human fetal oocytes and granulosa cells
throughout gestation and, based on the human WNT4 mutant
ovary phenotype and the Wnt4-null mouse model, likely regulates
oocyte survival, formation of germ cell cysts, and meiosis [31,32].
Several Wnt genes, including Wnt4, are also important for
mammary gland development downstream of steroid hormone
signals in the mouse (reviewed in [33]). Wnt4 itself appears to
mediate mammary ductal side branching during mouse pregnancy
[34]. Our finding that WNT4 was upregulated in the BPA-exposed
fetal uterus is consistent with our identification of progesterone
signaling as an upstream regulator of the differentially expressed
genes (Fig. 7). It is unclear at this point whether BPA-induced
alterations in WNT4 expression could occur in the ovary or
mammary gland and thereby contribute to the abnormalities in
follicle formation and mammary gland budding observed at birth
in offspring of BPA-exposed macaques [12,13].
In both mice and women, WNT and HOX gene expression
persists in the female reproductive tract and other tissues past
embryogenesis and into adulthood [27,35,36,37]. These findings
suggest ongoing roles for these genes in human adult tissues,
including regulation of endometrial function [27,38]. In the
mouse, Wnt4 is upregulated by estradiol, expressed in peri-
implantation decidua, and required for uterine gland formation
and proper adult uterine function [37,39]. Wnt5a mediates
stromal-epithelial interactions during uterine gland formation in
mouse neonates [26]. In humans, uterine gland formation is a
prolonged process that begins in utero but continues to occur
through adolescence based on the increasing extent of uterine
glands observed through puberty [40], suggesting that disruption
of WNT and/or HOX expression postnatally in girls could alter
gland formation. Prenatal BPA exposure can permanently modify
Figure 6. Top Ingenuity networks identified in GD165 Control v. BPA comparison. A. Post-Translational Modification, Protein Degradation,
Protein Synthesis (score = 37, 20 focus molecules, p value of top functions = 7.21E-05). B. Cellular, Embryonic, and Organ Development (score = 37, 20
focus molecules, p value of top functions = 6.53E-05).
doi:10.1371/journal.pone.0085894.g006
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expression of ERa and PR in mouse endometrium [41] and result
in persistent epigenetic alterations that affect estrogen-mediated
transcriptional responses such as upregulation of Hoxa10 expres-
sion [42,43]. These findings, combined with evidence here that
BPA may disrupt expression of multiple HOX and WNT genes in
the fetal primate uterus, suggest that the full impact of prenatal
BPA exposure on the uterus may not be evident until later in life.
Studies designed to answer this question will require long-term
followup of exposed animals into adulthood.
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